# Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem

> **NCT01732250** · PHASE4 · COMPLETED · sponsor: **Mical Paul** · enrollment: 406 (actual)

## Conditions studied

- Gram-Negative Bacterial Infections

## Interventions

- **DRUG:** Colistin
- **DRUG:** Meropenem

## Key facts

- **NCT ID:** NCT01732250
- **Lead sponsor:** Mical Paul
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2017-01-31
- **Final completion:** 2017-02-28
- **Target enrollment:** 406 (ACTUAL)
- **Last updated:** 2017-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01732250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01732250, "Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT01732250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*